The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer

Francesco Passiglia, Rafael Caparica, Elisa Giovannetti, Marco Giallombardo, Angela Listi, Patrizia Diana, Girolamo Cirrincione, Christian Caglevic, Luis E. Raez, Antonio Russo, Christian Rolfo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)385-392
JournalExpert Opinion on Investigational Drugs
Volume25
Issue number4
DOIs
Publication statusPublished - 2 Apr 2016

Cite this

Passiglia, Francesco ; Caparica, Rafael ; Giovannetti, Elisa ; Giallombardo, Marco ; Listi, Angela ; Diana, Patrizia ; Cirrincione, Girolamo ; Caglevic, Christian ; Raez, Luis E. ; Russo, Antonio ; Rolfo, Christian. / The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. In: Expert Opinion on Investigational Drugs. 2016 ; Vol. 25, No. 4. pp. 385-392.
@article{e337baff99ab4964b69b5f73e8ffb930,
title = "The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer",
keywords = "NTRK-inhibitors, NTRK1/2/3, targeted therapy, lung cancer, TrkA/B/C",
author = "Francesco Passiglia and Rafael Caparica and Elisa Giovannetti and Marco Giallombardo and Angela Listi and Patrizia Diana and Girolamo Cirrincione and Christian Caglevic and Raez, {Luis E.} and Antonio Russo and Christian Rolfo",
year = "2016",
month = "4",
day = "2",
doi = "10.1517/13543784.2016.1152261",
language = "English",
volume = "25",
pages = "385--392",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

Passiglia, F, Caparica, R, Giovannetti, E, Giallombardo, M, Listi, A, Diana, P, Cirrincione, G, Caglevic, C, Raez, LE, Russo, A & Rolfo, C 2016, 'The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer' Expert Opinion on Investigational Drugs, vol. 25, no. 4, pp. 385-392. https://doi.org/10.1517/13543784.2016.1152261

The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. / Passiglia, Francesco; Caparica, Rafael; Giovannetti, Elisa; Giallombardo, Marco; Listi, Angela; Diana, Patrizia; Cirrincione, Girolamo; Caglevic, Christian; Raez, Luis E.; Russo, Antonio; Rolfo, Christian.

In: Expert Opinion on Investigational Drugs, Vol. 25, No. 4, 02.04.2016, p. 385-392.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer

AU - Passiglia, Francesco

AU - Caparica, Rafael

AU - Giovannetti, Elisa

AU - Giallombardo, Marco

AU - Listi, Angela

AU - Diana, Patrizia

AU - Cirrincione, Girolamo

AU - Caglevic, Christian

AU - Raez, Luis E.

AU - Russo, Antonio

AU - Rolfo, Christian

PY - 2016/4/2

Y1 - 2016/4/2

KW - NTRK-inhibitors

KW - NTRK1/2/3

KW - targeted therapy

KW - lung cancer

KW - TrkA/B/C

U2 - 10.1517/13543784.2016.1152261

DO - 10.1517/13543784.2016.1152261

M3 - Article

VL - 25

SP - 385

EP - 392

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 4

ER -